vs
MIMEDX GROUP, INC.（MDXG）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是MIMEDX GROUP, INC.的1.8倍（$212.2M vs $118.1M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 12.9%，领先5.9%），MIMEDX GROUP, INC.同比增速更快（27.1% vs 8.6%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs 11.1%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
MDXG vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.8倍
$118.1M
营收增速更快
MDXG
高出18.5%
8.6%
净利率更高
RAMP
高出5.9%
12.9%
两年增速更快
MDXG
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $212.2M |
| 净利润 | $15.2M | $39.9M |
| 毛利率 | 83.9% | 71.9% |
| 营业利润率 | 17.8% | 18.6% |
| 净利率 | 12.9% | 18.8% |
| 营收同比 | 27.1% | 8.6% |
| 净利润同比 | 104.2% | 255.7% |
| 每股收益（稀释后） | $0.10 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRAMP
| Q4 25 | $118.1M | $212.2M | ||
| Q3 25 | $113.7M | $199.8M | ||
| Q2 25 | $98.6M | $194.8M | ||
| Q1 25 | $88.2M | $188.7M | ||
| Q4 24 | $92.9M | $195.4M | ||
| Q3 24 | $84.1M | $185.5M | ||
| Q2 24 | $87.2M | $176.0M | ||
| Q1 24 | $84.7M | $171.9M |
净利润MDXGRAMP
| Q4 25 | $15.2M | $39.9M | ||
| Q3 25 | $16.7M | $27.4M | ||
| Q2 25 | $9.6M | $7.7M | ||
| Q1 25 | $7.0M | $-6.3M | ||
| Q4 24 | $7.4M | $11.2M | ||
| Q3 24 | $8.1M | $1.7M | ||
| Q2 24 | $17.6M | $-7.5M | ||
| Q1 24 | $9.3M | $-5.4M |
毛利率MDXGRAMP
| Q4 25 | 83.9% | 71.9% | ||
| Q3 25 | 83.5% | 70.2% | ||
| Q2 25 | 81.1% | 70.1% | ||
| Q1 25 | 81.2% | 69.3% | ||
| Q4 24 | 81.8% | 71.9% | ||
| Q3 24 | 81.8% | 72.4% | ||
| Q2 24 | 83.0% | 70.6% | ||
| Q1 24 | 84.7% | 72.2% |
营业利润率MDXGRAMP
| Q4 25 | 17.8% | 18.6% | ||
| Q3 25 | 19.5% | 10.7% | ||
| Q2 25 | 12.5% | 3.7% | ||
| Q1 25 | 9.4% | -6.1% | ||
| Q4 24 | 11.9% | 7.5% | ||
| Q3 24 | 13.3% | 4.0% | ||
| Q2 24 | 26.9% | -3.0% | ||
| Q1 24 | 15.6% | -8.3% |
净利率MDXGRAMP
| Q4 25 | 12.9% | 18.8% | ||
| Q3 25 | 14.7% | 13.7% | ||
| Q2 25 | 9.8% | 4.0% | ||
| Q1 25 | 8.0% | -3.3% | ||
| Q4 24 | 8.0% | 5.7% | ||
| Q3 24 | 9.6% | 0.9% | ||
| Q2 24 | 20.2% | -4.3% | ||
| Q1 24 | 10.9% | -3.1% |
每股收益（稀释后）MDXGRAMP
| Q4 25 | $0.10 | $0.62 | ||
| Q3 25 | $0.11 | $0.42 | ||
| Q2 25 | $0.06 | $0.12 | ||
| Q1 25 | $0.05 | $-0.10 | ||
| Q4 24 | $0.05 | $0.17 | ||
| Q3 24 | $0.05 | $0.03 | ||
| Q2 24 | $0.12 | $-0.11 | ||
| Q1 24 | $0.06 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $403.4M |
| 总债务越低越好 | $18.0M | — |
| 股东权益账面价值 | $256.5M | $962.3M |
| 总资产 | $342.7M | $1.3B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资MDXGRAMP
| Q4 25 | $166.1M | $403.4M | ||
| Q3 25 | $142.1M | $376.9M | ||
| Q2 25 | $118.9M | $371.1M | ||
| Q1 25 | $106.4M | $420.8M | ||
| Q4 24 | $104.4M | $384.3M | ||
| Q3 24 | $88.8M | $348.4M | ||
| Q2 24 | $69.0M | $342.7M | ||
| Q1 24 | $48.5M | $368.9M |
总债务MDXGRAMP
| Q4 25 | $18.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $19.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDXGRAMP
| Q4 25 | $256.5M | $962.3M | ||
| Q3 25 | $238.9M | $943.8M | ||
| Q2 25 | $216.6M | $947.8M | ||
| Q1 25 | $202.8M | $948.9M | ||
| Q4 24 | $193.1M | $957.7M | ||
| Q3 24 | $181.0M | $932.1M | ||
| Q2 24 | $168.0M | $951.9M | ||
| Q1 24 | $155.7M | $949.1M |
总资产MDXGRAMP
| Q4 25 | $342.7M | $1.3B | ||
| Q3 25 | $319.0M | $1.2B | ||
| Q2 25 | $291.1M | $1.2B | ||
| Q1 25 | $270.4M | $1.3B | ||
| Q4 24 | $263.9M | $1.3B | ||
| Q3 24 | $243.9M | $1.2B | ||
| Q2 24 | $230.2M | $1.2B | ||
| Q1 24 | $221.7M | $1.2B |
负债/权益比MDXGRAMP
| Q4 25 | 0.07× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDXGRAMP
| Q4 25 | $25.0M | — | ||
| Q3 25 | $29.3M | $57.4M | ||
| Q2 25 | $14.4M | $-15.8M | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $18.8M | $45.1M | ||
| Q3 24 | $19.6M | $55.6M | ||
| Q2 24 | $21.8M | $-9.3M | ||
| Q1 24 | $6.0M | — |
自由现金流MDXGRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | — | $-16.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | — | $55.4M | ||
| Q2 24 | — | $-9.6M | ||
| Q1 24 | — | — |
自由现金流率MDXGRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | — |
资本支出强度MDXGRAMP
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 1.0% |
现金转化率MDXGRAMP
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | 2.09× | ||
| Q2 25 | 1.50× | -2.04× | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | 4.02× | ||
| Q3 24 | 2.42× | 32.10× | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RAMP
暂无分部数据
